Abbott Laboratories stock is emerging as a key way to play a potential rebound in healthcare, with analysts arguing that ...

Abbott's revenue has been flat over 15 months with steady Q3 EPS of $1.30, 7% growth, and upcoming Q4 international segment ...

We recently compiled a list of the 10 Best Investments During A Recession. The seventh stock on our list of best investments ...

Why Abbott’s Price Target Just Nudged Higher Abbott Laboratories has seen its implied fair value estimate edge to about ...

Abbott Laboratories (NYSE: ABT) doesn’t just pay dividends. It grows them. For 52 consecutive years. That’s Dividend King ...

With Abbott Laboratories set to release its earnings next week, ABT stock presents an intriguing contrarian trade following a weak spell.

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

This was the stock's fourth consecutive day of losses.

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 5.49%, ...

Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from ...

This was the stock's second consecutive day of losses.